Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptional profiling of LNGFR.FOXP3-expressing scurfy CD4+ T cells

ABSTRACT: Transcriptional profiling of LNGFR.FOXP3-expressing scurfy CD4+ T cells

PROVIDER: PRJNA698983 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Transcriptional profiling of LNGFR.FOXP3-expressing scurfy CD4+ T cells

Project description:We reported transcriptional characterization of LNGFR.FOXP3-expressing scurfy CD4+ T cells from lymph nodes, at day 35 after transfer in scurfy males, where they were able to rescue mice from scurfy autoimmune disease.

2021-02-03 | GSE166017 | GEO

Transcriptional profiling of CD45RO+CD57+CD4+ T cells

Project description:Transcriptional profiling of CD45RO+CD57+CD4+ T cells

| PRJNA555510 | ENA

PD-1+ and PD-1- CD4+ Teff and Treg cells in Glioblastoma and Health

Project description:<p>PD-1 is an important immune checkpoint inhibitor that shows great promise in the clinic, particularly for melanoma and lung cancers. Since PD-1 is also expressed on infiltrating CD4+ Treg and Teffector cells in glioblastoma, we sought to better understand the role of PD-1 on these infiltrating CD4+ Treg and Teffector cells. To this end, we performed functional and transcriptional profiling using CD4+ Treg and Teffector cells isolated from healthy donors and glioblastoma patients (from both tumors and blood).</p>

| phs001079 | dbGaP

CD4+ cell transcriptional profiling by RNA sequencing

Project description:<p>We use next generation sequencing to investigate the different transcriptomes of closely related CD4+ T-cells from healthy human donors to elucidate the genetic programs that underlie their specialized immune functions. Six cell types were included: Regulatory T-cells (CD25hiCD127low/neg with >95% FOXP3+ purity), regulatory T-cells activated using PMA/ionomycin, CD25-CD45RA+ ('naive' helper T-cells), CD25-CD45RO+ ('memory' helper T-cells), activated Th17 cells (>98% IL17A+ purity) and activated IL17-CD4+ T-cells (called 'ThPI'). Poly-T capture beads were used to isolate mRNA from total RNA, and fragment sizes of ~200 were sequenced from both ends on Illumina's genome analyzer. We confirm many of the canonical signature genes of T-cell populations, but also discover new genes whose expression is limited to specific CD4 T-cell lineages, including long non-coding RNAs. Additionally, we find that genes encoded at loci linked to multiple human autoimmune diseases are enriched for preferential expression upon T-cell activation, suggesting that an aberrant response to T-cell activation is fundamental to pathogenesis.</p>

| phs000626 | dbGaP

Proteomic profiling of HIV infection of human CD4 T cells

Project description:To systematically examine host-virus interaction in HIV infection, we used isobaric tag-based quantitative mass spectrometry to perform a proteomic profiling of HIV infection of human primary CD4 T cells.

| MSV000082987 | MassIVE

Transcriptional analysis of HIV-specific CD4+ T cells

Project description:Transcriptional analysis of HIV-specific CD4+ T cells

| PRJNA527037 | ENA

Transcriptional profiling of murine CD4+ T cells following treatment with the supercooling compound icilin

Project description:Transcriptional profiling of murine CD4+ T cells following treatment with the supercooling compound icilin

| PRJNA416867 | ENA

Transcriptional Profiling of Target CD4+ T-cells that Survive Cytotoxic T Cell Co-culture

Project description:Transcriptional Profiling of Target CD4+ T-cells that Survive Cytotoxic T Cell Co-culture

| PRJNA601976 | ENA

Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Pancreatic, Colorectal and Non-Small Cell Lung Cancers With KRAS G12V Mutations

Project description:This phase I trial studies the side effects and best dose of autologous CD8+ and CD4+ transgenic T cells expressing high affinity KRAS G12V mutation-specific T cell receptors (FH-A11KRASG12V-TCR) and to see how well they work in treating patients with pancreatic, colorectal, and non-small cell lung cancers that has spread from where it first started (primary site) to other places in the body (metastatic). T cells are infection fighting blood cells that can kill tumor cells. The T cells given in this study will come from the patient and will have a new gene put in them that makes them able to recognize KRAS G12V, a protein on the surface of tumor cells. These KRAS G12V-specific T cells may help the body’s immune system identify and kill KRAS G12V pancreatic, colorectal, and non-small cell lung cancers’ tumor cells.

| 92453 | ecrin-mdr-crc

Transcription profiling of IL-4-expressing CD4 T cells in the lung and lung-draining lymph nodes

Project description:Transcription profiling of IL-4-expressing CD4 T cells in the lung and lung-draining lymph nodes

| PRJNA517508 | ENA